CLINICAL TRIAL: PHASE I TRIAL OF ABRAXANE IN COMBINATION WITH GEMCITABINE IN SOL

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本研究的目的是了解与吉西他滨一起服用的 Abraxane 的最高剂量。 将测试不同剂量的 Abraxane。 所给予的吉西他滨量将是标准剂量——尚未测试不同剂量的吉西他滨。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to see the highest amount of Abraxane that can be given with gemcitabine. Different doses of Abraxane will be tested. The amount of gemcitabine that is given will be the standard dose - different doses of gemcitabine are not being tested.